EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β‐elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1

Jin Lan, Weili Zhang iD, Kaixuan Zeng, Cong Li, Jiahua He, Xinyue Li, Rong Yang, Jun Chi, Zhigang Hong, Weifeng Wang, Chi Zhou, Binyi Xiao und 8 weitere

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Jin Lan und 19 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Hauptthemen laut MEDLINE: Ferroptosis, Imatinib Mesylate, Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Beijing Xisike Clinical Oncology Research Foundation, Chih Kuang Scholarship for Outstanding Young Physician-Scientists of Sun Yat-sen University Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Imatinib has been widely used in gastrointestinal stromal tumours and significantly improved the prognosis of GIST patients, but approximately half of patients develop acquired treatment resistance, highlighting the urgency for novel therapeutic strategies.

Methods

A variety of bioinformatic tools and laboratory experiments, RNA sequencing, animal models and the thermal proteome profiling assay were employed to validate our findings and investigate the antitumour effects of β‐elemene.

Results

We found that imatinib‐resistant GIST was associated with negative regulation of ferroptosis activity, and inducing ferroptosis can enhance the sensitivity of resistant cells to imatinib. Furthermore, we found that β‐elemene enhances imatinib sensitivity in imatinib‐resistant GIST cells through inducing ferroptosis. Moreover, the combination treatment of β‐elemene and imatinib showed significantly increased antitumour efficacy, compared to each monotherapy, both in vitro and in vivo. Mechanistically, β‐elemene specifically targets N6AMT1, inhibiting its transcriptional repression function and activating the nuclear factor erythroid 2‐related factor 2 (NRF2)‐HMOX1 signalling pathway to induce ferroptosis.

Conclusion

Β‐elemene can target N6AMT1 and promote ferroptosis by increasing the expression of NRF2 and HMOX1. These findings suggest β‐elemene as a prospective therapeutic strategy to improve the sensitivity of imatinib in gastrointestinal stromal tumours. Key points l Imatinib resistance is associated with ferroptosis activity in GIST. l Combination of β‐elemene and imatinib effectively treats gastrointestinal stromal tumours both in vivo and in vitro. l β‐elemene promotes imatinib sensitivity in GIST through ferroptosis. l N6AMT1 is a potential target of β‐elemene. l β‐elemene targets N6AMT1 to promote imatinib sensitivity in imatinib‐resistant GIST cells via the NRF2/HMOX1 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisImatinib MesylateGastrointestinal Stromal TumorsGastrointestinal NeoplasmsSite-Specific DNA-Methyltransferase (Adenine-Specific)SesquiterpenesDrug Resistance, NeoplasmAntineoplastic Combined Chemotherapy ProtocolsGene Expression Regulation, NeoplasticSignal TransductionNF-E2-Related Factor 2Heme Oxygenase-1HumansAnimalsMiceCell Line, TumorMolecular Docking SimulationRNA-SeqXenograft Model Antitumor AssaysFemaleMice, Inbred BALB CDrug Synergism

Stichwörter der Autor:innen

ROSferroptosisgastrointestinal stromal tumoursimatinib resistanceβ‐elemene

Substanzen

Imatinib MesylateN6AMT1 protein, humanSite-Specific DNA-Methyltransferase (Adenine-Specific)beta-elemeneSesquiterpenesNF-E2-Related Factor 2Heme Oxygenase-1

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Precision Medical Research Institute, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, China.

ORCID-Profile: Weili Zhang, Weihao Li, Xiaojun Wu

Förderung

  • Natural Science Foundation of Guangdong Province
  • Beijing Xisike Clinical Oncology Research Foundation
  • Chih Kuang Scholarship for Outstanding Young Physician-Scientists of Sun Yat-sen University Cancer Center

Zitieren

APA

Lan, J., Zhang, W., Zeng, K., Li, C., He, J., Li, X., Yang, R., Chi, J., Hong, Z., Wang, W., Zhou, C., Xiao, B., Fan, W., Lin, J., Ou, Q., Fang, Y., Pan, Z., Peng, J., Li, W., & Wu, X. (2025). β‐elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70438

Vancouver

Lan J, Zhang W, Zeng K, Li C, He J, Li X, et al. β‐elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70438

BibTeX
@article{Lan2025,
  author = {Lan, Jin and Zhang, Weili and Zeng, Kaixuan and Li, Cong and He, Jiahua and Li, Xinyue and Yang, Rong and Chi, Jun and Hong, Zhigang and Wang, Weifeng and Zhou, Chi and Xiao, Binyi and Fan, Wenhua and Lin, Junzhong and Ou, Qingjian and Fang, Yujing and Pan, Zhizhong and Peng, Jianhong and Li, Weihao and Wu, Xiaojun},
  title = {β‐elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70438}
}
Kostenlos starten →